Ask Warren

Innogene

344860 · KOSDAQ · ₩344860 · 이노진

₩1,483▲ ₩18 (1.23%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −7.95%
Market cap
₩22B
Enterprise value
₩21B
P/E
—
P/B
1.8×
Dividend yield
6.1%
ROE
−1.4%
Net margin
−1.4%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−47.0% from the high

₩1,099Today: ₩1,422 – ₩1,500₩2,800

Returns

  • 1W+1.0%
  • 1M+6.4%
  • 3M+12.5%
  • 6M−6.2%
  • YTD−20.4%
  • 1Y−7.9%
Volume today
41,009
1.0× the 20-day average
Traded today
₩60M
Listed shares
15,030,000
EPS (12 months)
−₩11
Earnings yield −0.8%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

45Normal
  • BuzzNormalBuzz 45 of 100 (50 is a normal day for this stock).
  • MomentumStrong7.7% over the last month; the price is above its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Innogene stock overview

Innogene (이노진, KRX: 344860) is listed on KOSDAQ, in the Cosmetics sector. The company is a cosmeceutical business focused on hair loss and problem skin/regeneration, offering home care, scalp care devices, health functional foods and medicines to dermatology and medical clinics in Korea. Its shares closed at ₩1,483 on Oct 27, 2026, up 1.23% on the day, giving it a market value of ₩22B.

Key facts

Market cap
₩22B
Sector
Cosmetics
Latest price change
+1.23%
As of
Oct 27, 2026
Main business
The company is a cosmeceutical business focused on hair loss and problem skin/regeneration, offering home care, scalp care devices, health functional foods and medicines to dermatology and medical clinics in Korea.

Quick answers about Innogene

What does Innogene do?
The company is a cosmeceutical business focused on hair loss and problem skin/regeneration, offering home care, scalp care devices, health functional foods and medicines to dermatology and medical clinics in Korea. Its main products are hair loss care lines, which made up about 83% of 2025 sales, and skin beauty lines, and it exports to countries including the United States, China, Singapore, Hong Kong and Malaysia.
What is the market cap of Innogene?
The market capitalisation of Innogene was ₩22B at the close on Oct 27, 2026.
Who are the largest shareholders of Innogene?
According to the latest official filings, the largest reported holders are Lee Gwang-hoon (49.09%, as of Aug 24, 2026); Metamorphosis (18.96%, as of Aug 24, 2026); Kwon Deung-mun (5.68%, as of Sep 22, 2026).
When is the next earnings report from Innogene?
Korean companies rarely announce results dates in advance. Based on when Innogene filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.

Company profile

The company is a cosmeceutical business focused on hair loss and problem skin/regeneration, offering home care, scalp care devices, health functional foods and medicines to dermatology and medical clinics in Korea. Its main products are hair loss care lines, which made up about 83% of 2025 sales, and skin beauty lines, and it exports to countries including the United States, China, Singapore, Hong Kong and Malaysia.

Written by AI from the company's latest annual report.

Korean name
이노진
Sector
Cosmetics
Themes
K-beauty
CEO
이광훈, 정기철
Founded
Sep 2005
Listed
Feb 2023
Listed shares
15,030,000
Fiscal year ends
Month 12
Website
www.innogene.com/

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Innogene / 이노진 / 344860 / KRX:344860

Source: KRX statistical information